|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2550 CAD | +10.87% |
|
+8.51% | - |
| 06-02 | Vext Science, Inc. Opens Sixth Dispensary in Fairfield Ohio | CI |
| 05-21 | Vext Science, Inc., Q1 2026 Earnings Call, May 21, 2026 |
Company Valuation: Vext Science, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 69.14 | 26.42 | 47.76 | 28.38 | 46.69 | 40.43 | - | - |
| Change | - | -61.79% | 80.79% | -40.58% | 64.53% | -13.4% | - | - |
| Enterprise Value (EV) 1 | 76.78 | 58.63 | 77.63 | 63.27 | 46.69 | 26.53 | 40.53 | 52.53 |
| Change | - | -23.63% | 32.4% | -18.51% | -26.21% | -43.18% | 52.77% | 29.61% |
| P/E | - | - | 7.07x | -1.43x | -2.66x | -16.4x | 16.4x | -16.4x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | - | - | 0x | 0.2x | 0.2x | -0x | 0x |
| Capitalization / Revenue | 1.86x | 0.75x | 1.37x | 0.79x | 0.91x | 0.75x | 0.59x | 0.55x |
| EV / Revenue | 2.06x | 1.66x | 2.23x | 1.76x | 0.91x | 0.49x | 0.59x | 0.71x |
| EV / EBITDA | 5.73x | 3.88x | 14x | 6.91x | - | 1.7x | 2.05x | 2.39x |
| EV / EBIT | - | - | -9.9x | -5.66x | - | 133x | 9.89x | - |
| EV / FCF | -10.8x | -20x | 46x | 34.7x | 5.73x | 2.82x | 2.28x | 2.68x |
| FCF Yield | -9.25% | -5.01% | 2.17% | 2.88% | 17.4% | 35.5% | 43.8% | 37.4% |
| Dividend per Share 3 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 3 | - | - | 0.041 | -0.115 | -0.0958 | -0.014 | 0.014 | -0.014 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 37.24 | 35.41 | 34.81 | 36 | 51.37 | 53.8 | 68.95 | 74 |
| EBITDA 1 | 13.39 | 15.12 | 5.528 | 9.153 | - | 15.6 | 19.8 | 22 |
| EBIT 1 | - | - | -7.843 | -11.18 | - | 0.2 | 4.1 | - |
| Net income 1 | - | - | - | - | -17.99 | -2.3 | 2.37 | -1.6 |
| Net Debt 1 | 7.635 | 32.22 | 29.88 | 34.89 | - | -13.9 | 0.1 | 12.1 |
| Reference price 3 | 0.6400 | 0.2400 | 0.2900 | 0.1650 | 0.2550 | 0.2300 | 0.2300 | 0.2300 |
| Nbr of stocks (in thousands) | 136,713 | 148,963 | 217,484 | 247,443 | 251,034 | 247,684 | - | - |
| Announcement Date | 4/20/22 A | 3/22/23 A | 5/10/24 A | 3/31/25 A | 4/29/26 A | - | - | - |
1CAD in Million2USD in Million3CAD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -16.43x | 0.49x | 1.7x | - | 40.43M | |
| 14.3x | 1.18x | 5.92x | - | 234M | |
| 15.75x | - | - | - | 133M | |
| 10.27x | - | - | - | 131M | |
| -1.02x | 0.63x | 2.77x | - | 81.19M | |
| -1.5x | 1.04x | 5.77x | - | 77.04M | |
| Average | 3.56x | 0.83x | 4.04x | 116.06M | ||
| Weighted average by Cap. | 8.50x | 0.99x | 4.91x |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- VEXT Stock
- Valuation Vext Science, Inc.
Select your edition
All financial news and data tailored to specific country editions
